Metronidazole Oral: Uses, Side Effects, Interactions, Pictures ...



vaginosis cream :: Article Creator

Hello Wisp Review: Birth Control, UTIs, STIs And More

Wisp offers same-day consultations, discreet delivery or same-day pickup of prescription and over-the-counter medications, and the ability to get treatment without medical insurance.

Wisp ships free to all 50 states and all doctors are licensed and board-certified in the U.S. Anyone can use Wisp for one-time purchases for both prescription and over-the-counter medications, but there is also an option to sign up for a subscription to get recurring prescription deliveries or pick-up.

Wispcare is a separate option that is available for anyone who needs a one-time consultation or unlimited consultations (for a monthly fee) with a doctor. It is optional and gives you a no-wait consultation instead of waiting to make a doctor's appointment. Wispcare is only available for specific conditions and cannot be used for genital herpes, cold sores, urinary tract infections, yeast infections, bacterial vaginosis, birth control and emergency contraception. Wispcare is available for users who want to actually speak with a doctor about their symptoms instead of just taking a quiz.

To get started on Wisp, users begin by filling out a private medical form and taking the Symptoms Quiz, which asks questions about what users are looking for and what their symptoms are. From there, users are pointed in the right direction, whether that is an online consultation with a doctor or a link to purchase medication.

A provider will review responses and follow up via a phone call or secure chat within 24 hours, although most users can expect to hear back within two to four hours. When safe and necessary, providers will write a prescription. Users can then choose to get medication shipped free to their home in discreet packaging, or they can choose to pick up the medication same-day at a local pharmacy. Keep in mind that some medications are not available to be picked up at a pharmacy and must be delivered.

Wisp provides both prescription and OTC medications for the following:

  • Yeast infections
  • Bacterial vaginosis
  • Urinary tract infections
  • Birth control (birth control pills)
  • Emergency contraception
  • Delayed menstruation
  • Cold sores
  • Genital herpes
  • Sexually transmitted disease (STD) prevention
  • Medical abortion (offered in nine states where legal: Connecticut, New Mexico, California, Colorado, Illinois, Maine, Maryland, New York and Washington)
  • Intimate care (this includes lube, body wash and cream)
  • Skincare (this includes acne and wrinkle cream)
  • Wispcare is available for individuals looking to consult with a doctor to find out whether they need medication and what condition they may have. Wispcare provides consults for the below:

  • STDs
  • Premenstrual syndrome (PMS)
  • Reproductive health (including delayed menstruation, lactation support, genital inflammation or irritation, non-menstrual bleeding and bladder infection)
  • Menopause (hot flashes and vaginal dryness)
  • Sexual wellness (including low libido and pain and dryness)
  • Primary care (including eczema, skincare, fungal infections and asthma)
  • Refills for current conditions (including high blood pressure, arthritis, diabetes, thyroid and COPD)
  • Wispcare unlimited does not cover consultations for genital herpes, cold sore, UTI, yeast infections, bacterial vaginosis, birth control and emergency contraception. Prescriptions from Wispcare are for pharmacy pick-up only, and the site notes that some conditions will require an in-person evaluation.

    Wisp also offers resources to help people learn more about common conditions, with pages explaining causes, symptoms and treatments of conditions like yeast infections and BV. These are free to access and can be accessed by anyone.

    While Wisp offers pharmacy pick-up or delivery for most medications, some medications will only be available for delivery. These include compound medications, which are usually ointments and creams. Since these are made by combining two or more drugs and are tailored to the person getting them, they must be prescribed by doctors and can only be delivered.


    Dare's (DARE) Xaciato Gets FDA Nod For Bacterial Vaginosis

    Daré Bioscience, Inc. DARE has announced that the FDA approved Xaciato (clindamycin phosphate vaginal gel, 2%) for the treatment of bacterial vaginosis in females 12 years of age and older.

    Xaciato was formerly known as DARE-BV1.

    We note that Xaciato received both Qualified Infectious Disease Product (QIDP) and Fast Track designations from the FDA for the treatment of bacterial vaginosis. Due to the QIDP designation, Xaciato is expected to receive a five-year extension of the three years of market exclusivity available to the product based on the submission of new clinical data essential to its approval.

    Daré Bioscience is currently looking for partners to market Xaciato in the United States. A commercial launch is expected in 2022.

    The approval will boost the growth prospects of the company as this is the first approved product for Daré Bioscience.

    The new drug application was supported by positive results from the DARE-BVFREE study, which evaluated Xaciato in women diagnosed with bacterial vaginosis.

    Bacterial vaginosis, the most common cause of vaginitis worldwide, is estimated to affect approximately 21 million women in the United States.

    The stock has rallied 58.3% so far this year against the industry's 19.6% decline.

    Zacks Investment Research

    Image Source: Zacks Investment Research

    Daré Bioscience's product portfolio also includes potential first-in-category candidates in clinical development - Ovaprene, a novel, hormone-free monthly contraceptive for which it has a license agreement with Bayer BAYRY. Further, it comprises sildenafil cream, 3.6%, a proprietary cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder.

    In January 2020, the company entered into a license agreement with Bayer regarding the further development and commercialization of Ovaprene in the United States. The company received a $1.0 million upfront license fee payment from Bayer upon execution of the agreement.

    Story continues

    The company continues to enroll patients in its phase IIb RESPOND study of sildenafil cream, 3.6%.

    Zacks Rank & Stocks to Consider

    Daré Bioscience currently carries a Zacks Rank #3 (Hold). A couple of better-ranked stocks in the healthcare sector are Sarepta Therapeutics, Inc. SRPT and Viking Therapeutics VKTX, both carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

    Estimates for Sarepta have narrowed from a loss per share of $6.95 to $4.99 for 2021 and from $4.83 to $3.61 for 2022 in the past 30 days. SRPT delivered an earnings surprise of 11.06%, on average, in the last four quarters.

    Estimates for Viking Therapeutics have narrowed to a loss per share of $3.16 from $3.55 for 2021 and to $3.47 from $3.63 for 2022 in the past 30 days. VKTX delivered an earnings surprise of 2.06%, on average, in the last four quarters.

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

    Bayer Aktiengesellschaft (BAYRY) : Free Stock Analysis Report

    Sarepta Therapeutics, Inc. (SRPT) : Free Stock Analysis Report

    Viking Therapeutics, Inc. (VKTX) : Free Stock Analysis Report

    Dare Bioscience, Inc. (DARE) : Free Stock Analysis Report

    To read this article on Zacks.Com click here.

    Zacks Investment Research


    Bacterial Vaginosis Drug Market Future Upcoming Analysis Report Till 2031

    "Bacterial Vaginosis Drug Market" Size, Share, Growth Report 2023-2031No. Of pages: 121 Report which offers an in-depth analysis Grounded on Applications (Hospital, Pharmacy, Others), and Types (Rx, OTC) and expected to grow annually by magnificent (CAGR 2023 - 2031).

    Bacterial Vaginosis Drug market report focuses on Supply-Demand Scenario, Key Raw Material Analysis, SWOT Analysis. It delivers an unbiased evaluation of the market's performance, highlighting the latest industry advancements and innovative practices.

    Who is the Largest Companies of Bacterial Vaginosis Drug Market?

    Bayer LGM Pharma AstraZeneca Starpharma Holdings Cardinal Health Pfizer Symbiomix Therapeutics Sun Pharmaceutical Industries Starpharma Allergan Teva Pharmaceutical Industries Mylan Sanofi Novartis

    Get a Sample PDF of report - https://www.360marketupdates.Com/enquiry/request-sample/23403746

    Key Takeaways same point covering: -

    Consumer Insights, Data-Driven Decision Making, Trend Identification, Risk Reduction, Competitive Analysis, Global Perspective, Quantitative vs. Qualitative, Digital Evolution, Ethical Considerations, Continuous Process, Budgeting, Actionable Insights, Segmentation, Future Forecasting and other.

    Short Description About Bacterial Vaginosis Drug Market:

    Global Bacterial Vaginosis Drug Market is expected to increase during the forecasted period due to the rising number of Bacterial Vaginosis Drug. In 2023, the industry is growing at a steady rate and with the rising adoption of strategies by key manufacturers, the market is expected to rise over the projected horizon.

    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and its anticipated to reach USD 1215.68 million in 2031, with a CAGR of 3.79% during the forecast years.

    Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs in the vagina, which is caused by a large number of bacteria.

    This report covers a research time span from 2018 to 2031, and presents a deep and comprehensive analysis of the global Bacterial Vaginosis Drug market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.

    Analysis of the Bacterial Vaginosis Drug Market by Type: -

    Rx OTC

    Analysis of the Bacterial Vaginosis Drug Market by Application: -

    Hospital Pharmacy Others

    Get a Sample PDF of the Bacterial Vaginosis Drug Market Report 2031

    Global Bacterial Vaginosis Drug Market Trends and Marketing Channels Analyzed: The report delves into the analysis of market trends, development, and marketing channels in the global Bacterial Vaginosis Drug market. Additionally, the report evaluates the feasibility of new investment projects and provides overall research conclusions.

    Regions and Top Countries Data: -

    The report provides a detailed regional analysis of the global Bacterial Vaginosis Drug market, covering the business growth of various sectors at the regional and country levels. It includes country-wise volume analysis and region-wise market size analysis for the historical and forecast periods from 2018 to 2031.

    Major regions covered in the report:

    North America

    (USA, Canada, Mexico)

    Europe

    (Germany, UK, France, Russia, Italy, Rest of Europe)

    Asia-Pacific

    (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

    South America

    (Brazil, Argentina, Columbia, Rest of South America)

    Middle East and Africa

    (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

    Important Highlights of the report:

    This research report reveals this business overview, product overview, market share, demand and supply ratio, supply chain analysis, and import/export details

    The industry report captivates different approaches and procedures endorsed by the market key players to make crucial business decisions

    The historical and current data is provided in the report based on which the future projections are made and the industry analysis is performed

    Porters five forces analysis, value chain analysis, SWOT analysis are some additional important parameters used for the analysis of market growth

    The report provides the clients with the facts and figures about the market on the basis of evaluation of the industry through primary and secondary research methodologies

    Get a sample PDF of the report at - https://www.360marketupdates.Com/enquiry/request-sample/23403746

    Some of the Key Elements that a Market Research Report Typically Includes Are:

    Executive Summary: An overview of the key findings, conclusions, and recommendations from the report. It also contains an overview of the market, industry, or sector being analyzed, including market size, growth rate, and key trends.

    Market Segmentation: A breakdown of the market into different segments based on factors such as product type, products applications, and geographic region.

    Competitive Analysis: An analysis of the key players in the market, their market share, competitive strategies, and strengths and weaknesses.

    Customer Analysis: An analysis of the customer base, including their preferences, buying behavior, and demographics.

    Market Trends: An analysis of current and emerging trends in the market, including technological advancements, changes in customer behavior, and shifts in the competitive landscape.

    SWOT Analysis: An analysis of the markets strengths, weaknesses, opportunities, and threats.

    Forecasting: A projection of future market trends and growth opportunities.

    Get a sample PDF of the report at - https://www.360marketupdates.Com/enquiry/request-sample/23403746

    Bacterial Vaginosis Drug Market - 2023 Analysis Report Covers Answers to your following Questions:

    What are the current global trends in the Bacterial Vaginosis Drug market? Will there be an increase or decline in demand in the upcoming years?

    What is the projected demand for different types of Bacterial Vaginosis Drug products? What are the upcoming trends and applications in the industry?

    What are the estimated projections for the global Bacterial Vaginosis Drug industries in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

    How will strategic developments shape the industry in the mid to long-term?

    What factors contribute to the final price of Bacterial Vaginosis Drug products? What raw materials are used in their manufacturing?

    How significant is the opportunity for the Bacterial Vaginosis Drug market? How will the increasing use of Bacterial Vaginosis Drug products in mining affect the overall market growth rate?

    What is the current value of the global Bacterial Vaginosis Drug market, and how much is it worth?

    Customization of the Report

    Certainly. Our report can be customized to meet your specific requirements. We understand that our clients have unique needs and we strive to provide customized, high-quality solutions that enable them to effectively identify market opportunities, overcome challenges, and develop successful strategies to stay ahead in the competitive landscape. With our multi-dimensional and deep-level analysis, we can provide you with the necessary insights to make informed decisions and gain a competitive power

    Inquire more and share questions if any before the purchase on this report at - https://www.360marketupdates.Com/enquiry/pre-order-enquiry/23403746

    Major Points from Table of Contents:

    1 Bacterial Vaginosis Drug Market Overview1.1 Market Definition and Product Scope 1.2 Global Bacterial Vaginosis Drug Market Size and Growth Rate 2018-2031 1.2.1 Global Bacterial Vaginosis Drug Market Growth or Decline Analysis 1.3 Market Key Segments Introduction 1.3.1 Types of Bacterial Vaginosis Drug 1.3.2 Applications of Bacterial Vaginosis Drug 1.4 Market Dynamics 1.4.1 Drivers and Opportunities 1.4.2 Limits and Challenges 1.4.3 Impacts of Global Inflation on Bacterial Vaginosis Drug Industry

    2 Industry Chain Analysis2.1 Bacterial Vaginosis Drug Raw Materials Analysis 2.2 Bacterial Vaginosis Drug Cost Structure Analysis 2.3 Global Bacterial Vaginosis Drug Average Price Estimate and Forecast (2018-2031) 2.4 Factors Affecting the Price of Bacterial Vaginosis Drug 2.5 Market Channel Analysis 2.6 Major Downstream Customers Analysis

    3 Industry Competitive Analysis3.1 Market Concentration Ratio and Market Maturity Analysis 3.2 New Entrants Feasibility Analysis 3.3 Substitutes Status and Threats Analysis

    4 Company Profiles5 Bacterial Vaginosis Drug Market - By Trade Statistics5.1 Global Bacterial Vaginosis Drug Export and Import 5.2 United States Bacterial Vaginosis Drug Export and Import Volume (2018-2023) 5.3 United Kingdom Bacterial Vaginosis Drug Export and Import Volume (2018-2023) 5.4 China Bacterial Vaginosis Drug Export and Import Volume (2018-2023) 5.5 Japan Bacterial Vaginosis Drug Export and Import Volume (2018-2023) 5.6 India Bacterial Vaginosis Drug Export and Import Volume (2018-2023)

    6 North America Bacterial Vaginosis Drug Market Overview Analysis6.1 North America Bacterial Vaginosis Drug Market Development Status (2018-2023) 6.2 United States Bacterial Vaginosis Drug Market Development Status (2018-2023) 6.3 Canada Bacterial Vaginosis Drug Market Development Status (2018-2023) 6.4 Mexico Bacterial Vaginosis Drug Market Development Status (2018-2023)

    Get a sample PDF of the report at - https://www.360marketupdates.Com/enquiry/request-sample/23403746

    7 Europe Bacterial Vaginosis Drug Market Overview Analysis7.1 Europe Bacterial Vaginosis Drug Market Development Status (2018-2023) 7.2 Germany Bacterial Vaginosis Drug Market Development Status (2018-2023) 7.3 United Kingdom Bacterial Vaginosis Drug Market Development Status (2018-2023) 7.4 France Bacterial Vaginosis Drug Market Development Status (2018-2023) 7.5 Italy Bacterial Vaginosis Drug Market Development Status (2018-2023) 7.6 Spain Bacterial Vaginosis Drug Market Development Status (2018-2023)

    8 Asia Pacific Bacterial Vaginosis Drug Market Overview Analysis8.1 Asia Pacific Bacterial Vaginosis Drug Market Development Status (2018-2023) 8.2 China Bacterial Vaginosis Drug Market Development Status (2018-2023) 8.3 Japan Bacterial Vaginosis Drug Market Development Status (2018-2023) 8.4 South Korea Bacterial Vaginosis Drug Market Development Status (2018-2023) 8.5 Southeast Asia Bacterial Vaginosis Drug Market Development Status (2018-2023) 8.6 India Bacterial Vaginosis Drug Market Development Status (2018-2023)

    9 Middle East and Africa Bacterial Vaginosis Drug Market Overview Analysis9.1 Middle East and Africa Bacterial Vaginosis Drug Market Development Status (2018-2023) 9.2 Saudi Arabia Bacterial Vaginosis Drug Market Development Status (2018-2023) 9.3 UAE Bacterial Vaginosis Drug Market Development Status (2018-2023) 9.4 South Africa Bacterial Vaginosis Drug Market Development Status (2018-2023)

    10 South America Bacterial Vaginosis Drug Market Overview Analysis10.1 South America Bacterial Vaginosis Drug Market Development Status (2018-2023) 10.2 Brazil Bacterial Vaginosis Drug Market Development Status (2018-2023) 10.3 Argentina Bacterial Vaginosis Drug Market Development Status (2018-2023)

    11 Bacterial Vaginosis Drug Market - By Regions11.1 Global Bacterial Vaginosis Drug Sales by Regions (2018-2023) 11.2 Global Bacterial Vaginosis Drug Value by Regions (2018-2023) 11.3 Bacterial Vaginosis Drug Value and Growth Rate (2018-2023) by Regions 11.3.1 North America Bacterial Vaginosis Drug Value and Growth Rate (2018-2023) 11.3.2 Europe Bacterial Vaginosis Drug Value and Growth Rate (2018-2023) 11.3.3 Asia Pacific Bacterial Vaginosis Drug Value and Growth Rate (2018-2023) 11.3.4 Middle East and Africa Bacterial Vaginosis Drug Value and Growth Rate (2018-2023) 11.3.5 South America Bacterial Vaginosis Drug Value and Growth Rate (2018-2023)And More..

    Get a Sample Copy of the Bacterial Vaginosis Drug Report 2023

    Key Reasons to Purchase:

    - To gain insightful analyses of the market and have comprehensive understanding of the global Bacterial Vaginosis Drug Market and its commercial landscape.

    - Assess the production processes, major issues, and solutions to mitigate the development risk.

    - To understand the most affecting driving and restraining forces in the Bacterial Vaginosis Drug Market and its impact in the global market.

    - Learn about the Bacterial Vaginosis Drug Market strategies that are being adopted by leading respective organizations.

    - To understand the future outlook and prospects for the Bacterial Vaginosis Drug Market.

    - Besides the standard structure reports, we also provide custom research according to specific requirements

    Purchase this report (Price PPP USD for a single-user license) - https://www.360marketupdates.Com/purchase/23403746

    About Us:

    Market is changing rapidly with the ongoing expansion of the industry. Advancement in technology has provided todays businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies a head start in planning and an edge over the competitors. 360marketupdatesis a credible source for gaining the market reports that will provide you with the lead your business needs.

    Contact Us:

    Web:https://www.360marketupdates.Com

    Email:sales@360marketupdates.Com

    Phone:US +(1) 424 253 0946 / UK +(44) 203 239 8187

    Press Release Distributed by The Express Wire

    To view the original version on The Express Wire visit Bacterial Vaginosis Drug Market Future upcoming Analysis Report till 2031

    COMTEX_440341612/2598/2023-09-16T11:43:24

    © 2023 Benzinga.Com. Benzinga does not provide investment advice. All rights reserved.






    Comments

    Popular posts from this blog

    Keto crotch: Is it real and how to treat it

    Shave your pubic hair if you want, but not at these times